Sight Sciences (SGHT)
(Delayed Data from NSDQ)
$3.49 USD
+0.02 (0.58%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $3.48 -0.01 (-0.29%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Sight Sciences, Inc. has a market cap of $179.38M, which represents its share price of $3.47 multiplied by its outstanding shares number of 51.70M. As a small-cap company, SGHT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SGHT 3.49 +0.02(0.58%)
Will SGHT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SGHT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGHT
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks
Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
SGHT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
Artivion (AORT) Lags Q1 Earnings Estimates
Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics
Other News for SGHT
Sight Sciences (SGHT) Reveals Cost-Efficient TearCare System for Eye Disease
Sight Sciences announces results of CUA assessing TearCare system
Sight Sciences announces publication of 24-month results of SAHARA RCT
Sight Sciences (SGHT) Publishes Promising 24-Month Results from SAHARA Trial